BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27556184)

  • 1. Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis.
    Kim EH; Song HS; Yoo SH; Yoon M
    Oncotarget; 2016 Oct; 7(40):65125-65136. PubMed ID: 27556184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation.
    Kim EH; Kim YH; Song HS; Jeong YK; Lee JY; Sung J; Yoo SH; Yoon M
    Oncotarget; 2016 Sep; 7(38):62267-62279. PubMed ID: 27556699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Treating Fields Inhibit the Metastatic Potential of Osteosarcoma Cells.
    Oh JY; Lee YJ; Kim EH
    Technol Cancer Res Treat; 2020; 19():1533033820947481. PubMed ID: 32938326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.
    Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX
    Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.
    Zhu P; Zhu JJ
    Chin Clin Oncol; 2017 Aug; 6(4):41. PubMed ID: 28841803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia enhances the migration and invasion of human glioblastoma U87 cells through PI3K/Akt/mTOR/HIF-1α pathway.
    Huang W; Ding X; Ye H; Wang J; Shao J; Huang T
    Neuroreport; 2018 Dec; 29(18):1578-1585. PubMed ID: 30371540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Candidate Tumor Suppressor Gene SLC8A2 Inhibits Invasion, Angiogenesis and Growth of Glioblastoma.
    Qu M; Yu J; Liu H; Ren Y; Ma C; Bu X; Lan Q
    Mol Cells; 2017 Oct; 40(10):761-772. PubMed ID: 29047259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rh2 inhibits metastasis of glioblastoma multiforme through Akt-regulated MMP13.
    Guan N; Huo X; Zhang Z; Zhang S; Luo J; Guo W
    Tumour Biol; 2015 Sep; 36(9):6789-95. PubMed ID: 25835975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUNX1 Regulates Migration, Invasion, and Angiogenesis via p38 MAPK Pathway in Human Glioblastoma.
    Sangpairoj K; Vivithanaporn P; Apisawetakan S; Chongthammakun S; Sobhon P; Chaithirayanon K
    Cell Mol Neurobiol; 2017 Oct; 37(7):1243-1255. PubMed ID: 28012022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-PKcs deficiency inhibits glioblastoma cell-derived angiogenesis after ionizing radiation.
    Liu Y; Zhang L; Liu Y; Sun C; Zhang H; Miao G; Di CX; Zhou X; Zhou R; Wang Z
    J Cell Physiol; 2015 May; 230(5):1094-103. PubMed ID: 25294801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.
    Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG
    Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition.
    Lin JJ; Zhao TZ; Cai WK; Yang YX; Sun C; Zhang Z; Xu YQ; Chang T; Li ZY
    Oncotarget; 2015 Jul; 6(19):17107-20. PubMed ID: 25940798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
    Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
    Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells.
    Jadhav U; Chigurupati S; Lakka SS; Mohanam S
    Int J Oncol; 2004 Nov; 25(5):1407-14. PubMed ID: 15492832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.
    Pang H; Zheng Y; Zhao Y; Xiu X; Wang J
    Biochem Biophys Res Commun; 2015 Dec; 468(4):739-45. PubMed ID: 26556542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol Inhibits the Invasion of Glioblastoma-Initiating Cells via Down-Regulation of the PI3K/Akt/NF-κB Signaling Pathway.
    Jiao Y; Li H; Liu Y; Guo A; Xu X; Qu X; Wang S; Zhao J; Li Y; Cao Y
    Nutrients; 2015 Jun; 7(6):4383-402. PubMed ID: 26043036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM.
    Yue S; Wang L; Zhang H; Min Y; Lou Y; Sun H; Jiang Y; Zhang W; Liang A; Guo Y; Chen P; Lv G; Wang L; Zong Q; Li Y
    Tumour Biol; 2015 Sep; 36(9):6741-9. PubMed ID: 25833697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion.
    Miekus K; Kijowski J; Sekuła M; Majka M
    Oncol Rep; 2012 Nov; 28(5):1903-9. PubMed ID: 22941268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.